Hiroyoshi Kunimoto
Yokohama City University(JP)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation, Histone Deacetylase Inhibitors Research, Cancer Genomics and Diagnostics, Protein Degradation and Inhibitors
Most-Cited Works
- → Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers(2017)142 cited
- → TET2 as an epigenetic master regulator for normal and malignant hematopoiesis(2014)109 cited
- → Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity(2017)100 cited
- → Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab(2008)91 cited
- → Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients(2014)80 cited
- → Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells(2012)63 cited
- → OGT Regulates Hematopoietic Stem Cell Maintenance via PINK1-Dependent Mitophagy(2021)60 cited
- → TET2: A cornerstone in normal and malignant hematopoiesis(2020)55 cited
- → Effect of Early Posttransplantation Tacrolimus Concentration on the Development of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors(2011)49 cited
- → Genetic basis of myeloid transformation in familial platelet disorder/acute myeloid leukemia patients with haploinsufficient RUNX1 allele(2016)29 cited